Procurement notices · Find a Tender + Contracts Finder

Notices

Every UK public-sector procurement notice in one board — open opportunities, closed tenders, awards, and pre-market signals. Filter by deadline, value or CPV, and save your search as an alert.

Closing 24h

Open notices

Closing this week

Don’t miss

Open · all

70,824

Live opportunities

Posted · 24h

200

New notices

Posted · 30d

12,607

All notice types

Awarded · 7d

1,559

Market signal

ActiveView: Closed Clear all

165,209 noticesclosed · sorted by publication date

Page 19 of 8261

Time to close

Value

Type

Buyer

Notice

CLOSED

20 Apr

—

Estimated

Closed

BALFOUR BEATTY CIVIL ENGINEERING LIMITED

A66 - Demolition

Construction work· Published 07 Apr

Notice peek

ClosedFTS · 04ee91

Provision of Hypertension and Lipids Optimisation Project

NHS Norfolk and Waveney Integrated Care Board

Status

cancelled

Estimated

—

Services

Published

24 Nov 2025

Key facts

Notice ID: ocds-h6vhtk-04ee91
CPV code: 85323000 · Health & social
Contract type: services
Source: Find a Tender

Timeline

Published
24 Nov 2025

Description

This is a notice to inform the market the procurement has been abandoned. NHS Norfolk and Waveney Integrated Care Board sought to procure a Hypertension and Lipids Optimisation Project. The successful provider staff was expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients. NHS Norfolk and Waveney Integrated Care Board sought to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software. The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management. The successful provider is was expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort. Prescribers must be able to initiate relevant medicines. Prescribers must initiate medicines in line with N&W criteria. Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary. Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance. The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.